Latest Breaking News On - European medicines agency commences review - Page 1 : comparemela.com

European Medicines Agency Commences Review of Aripiprazole 2-Month Long-Acting Injectable for the Maintenance Treatment of Schizophrenia in Adult Patients Stabilised with AripiprazoleOtsuka Pharmaceutical Europe Ltd. (“Otsuka”) and H. Lundbeck A/S (“Lundbeck”) today announce that the European.

United statesOtsuka europeThomas mikkel mortensenAlison rossAbilify maintenaOtsuka united kingdom pharma europe ltdOtsuka pharmaceutical company ltdWorld health organisationOtsuka pharmaceutical europe ltdEuropean medicines agencyEuropean medicines agency commencesMedia relations lead corpOtsuka holdings co ltdEuropean medicines agency commences reviewMonth long acting injectableMaintenance treatment